LETTER TO THE EDITOR
Detailed mechanism of SGLT2 inhibitor therapy on preventing arrhythmia recurrence after atrial fibrillation ablation
Sayaka Matsumoto,
Sayaka Matsumoto
Second Department of Internal Medicine, University of Toyama, Toyama, Japan
Search for more papers by this author Naoya Kataoka MD,
Naoya Kataoka MD
Second Department of Internal Medicine, University of Toyama, Toyama, Japan
Search for more papers by this author Teruhiko Imamura MD, PhD,
Corresponding Author
Teruhiko Imamura MD, PhD
Second Department of Internal Medicine, University of Toyama, Toyama, Japan
Correspondence Teruhiko Imamura, MD, PhD, Second Department of Internal Medicine, University of Toyama, 2630 Sugitani Toyama, Toyama 930-0194, Japan.
Email: [email protected]
Search for more papers by this author
Sayaka Matsumoto,
Sayaka Matsumoto
Second Department of Internal Medicine, University of Toyama, Toyama, Japan
Search for more papers by this author Naoya Kataoka MD,
Naoya Kataoka MD
Second Department of Internal Medicine, University of Toyama, Toyama, Japan
Search for more papers by this author Teruhiko Imamura MD, PhD,
Corresponding Author
Teruhiko Imamura MD, PhD
Second Department of Internal Medicine, University of Toyama, Toyama, Japan
Correspondence Teruhiko Imamura, MD, PhD, Second Department of Internal Medicine, University of Toyama, 2630 Sugitani Toyama, Toyama 930-0194, Japan.
Email: [email protected]
Search for more papers by this author
First published: 29 July 2024
No abstract is available for this article.
REFERENCES
- 1Qi D, Guan X, Liu X, Liu L, Liu Z, Zhang J. Relationship between sodium-glucose cotransporter 2 inhibitors and atrial fibrillation recurrence after pulmonary vein isolation in patients with type 2 diabetes and persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2024; 35: 1799-1805. doi:10.1111/jce.16369
- 2Park JW, Yu HT, Kim TH, et al. Mechanisms of long-term recurrence 3 years after catheter ablation of atrial fibrillation. JACC: Clin Electrophysiol. 2020; 6(8): 999-1007.
- 3De Becker B, El Haddad M, De Smet M, et al. Early atrial fibrillation recurrence post catheter ablation: analysis from insertable cardiac monitor in the era of optimized radiofrequency ablation. Heart Rhythm. 2024; 21(5): 521-529.
- 4Delanaye P, Scheen AJ. The diuretic effects of SGLT2 inhibitors: a comprehensive review of their specificities and their role in renal protection. Diabetes Metab. 2021; 47(6):101285.
- 5Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis. J Am Coll Cardiol. 2017; 70(16): 2022-2035.